Compare Wells Fargo & Co (WFC) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wells Fargo & Co vs GeneDx Holdings Corp — how do they compare? Wells Fargo & Co trades at $87.8 (market cap $261.45B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Wells Fargo & Co is far larger — about 145.3× GeneDx Holdings Corp's market cap, and Wells Fargo & Co pays a 2.09% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WFC | WGS | |
|---|---|---|
Market Cap | $261.45B | $1.80B |
Sector | Financials | Technology |
52-Week High | $96.40 | $167.51 |
52-Week Low | $73.42 | $34.51 |
Dividend Yield | 2.09% | — |
Enterprise Value | — | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
